The director of the infectious diseases unit at Hillel Yaffe Hospital, Dr. Michal Stein, told Reshet Bet about a new medicine being developed to combat the coronavirus.
"We are hesitant about the promises we made of the first mediciine, its 30% efficacy, and further reservations. It has not yet been approved, but we are waiting for the second drug that according to clinical trials is more effective," said Stein.